EMAIL THIS PAGE TO A FRIEND

Environmental science and pollution research international

Determination of selected pharmaceuticals in tap water and drinking water treatment plant by high-performance liquid chromatography-triple quadrupole mass spectrometer in Beijing, China.


PMID 25196960

Abstract

A simultaneous determination method of 14 multi-class pharmaceuticals using solid-phase extraction (SPE) followed by high-performance liquid chromatography-tandem mass spectrometer (HPLC-MS/MS) was established to measure the occurrence and distribution of these pharmaceuticals in tap water and a drinking water treatment plant (DWTP) in Beijing, China. Target compounds included seven anti-inflammatory drugs, two antibacterial drugs, two lipid regulation drugs, one antiepileptic drug, and one hormone. Limits of detection (LODs) and limits of quantitation (LOQs) ranged from 0.01 to 1.80 ng/L and 0.05 to 3.00 ng/L, respectively. Intraday and inter-day precisions, recoveries of different matrices, and matrix effects were also investigated. Of the 14 pharmaceutical compounds selected, nine were identified in tap water of Beijing downtown with the concentration up to 38.24 ng/L (carbamazepine), and the concentration levels of detected pharmaceuticals in tap water (<5 ng/L for most pharmaceuticals) were lower than previous studies in other countries. In addition, ten and six pharmaceuticals were measured in raw water and finished water at the concentration ranged from 0.10 to 16.23 and 0.13 to 17.17 ng/L, respectively. Five compounds were detected most frequently in DWTP, namely antipyrine, carbamazepine, isopropylantipyrine, aminopyrine, and bezafibrate. Ibuprofen was found to be the highest concentration pharmaceutical during DWTP, up to 53.30 ng/L. DWTP shows a positive effect on the removal of most pharmaceuticals with 81.2-99.5 % removal efficiencies, followed by carbamazepine with 55.4 % removal efficiency, but it has no effect for removing ibuprofen and bezafibrate.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

197777
2-(p-Chlorophenoxy)-2-methylpropionic acid, 97%
C10H11ClO3
D8015
4-Dimethylaminoantipyrine, reactive nitrogen species scavenger
C13H17N3O
A5882
Antipyrine, analytical standard
C11H12N2O
10784
Antipyrine, tested according to Ph.Eur.
C11H12N2O
10790
Antipyrine, ≥99.0% (RT)
C11H12N2O
90567
Antipyrine, analytical reference material
C11H12N2O
B7273
Bezafibrate, ≥98%, solid
C19H20ClNO4
72516
Bezafibrate, analytical reference material
C19H20ClNO4
B1115000
Bezafibrate, European Pharmacopoeia (EP) Reference Standard
C19H20ClNO4
90323
Clofibric acid, analytical reference material
C10H11ClO3
55264
Ibuprofen-d3, analytical standard
C13D3H15O2
1356632
Ketoprofen, United States Pharmacopeia (USP) Reference Standard
C16H14O3
K2000000
Ketoprofen, European Pharmacopoeia (EP) Reference Standard
C16H14O3
34016
Ketoprofen, VETRANAL, analytical standard
C16H14O3
PHR1375
Ketoprofen, Pharmaceutical Secondary Standard; Certified Reference Material
C16H14O3
46482
Naproxen, VETRANAL, analytical standard
C14H14O3
PHR1040
Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material
C14H14O3
N0250000
Naproxen, European Pharmacopoeia (EP) Reference Standard
C14H14O3
1457301
Naproxen, United States Pharmacopeia (USP) Reference Standard
C14H14O3
S7507
Sulfamethoxazole, analytical standard
C10H11N3O3S
76177
Sulfamethoxazole, certified reference material, TraceCERT®
C10H11N3O3S
31737
Sulfamethoxazole, VETRANAL, analytical standard
C10H11N3O3S
PHR1126
Sulfamethoxazole, Pharmaceutical Secondary Standard; Certified Reference Material
C10H11N3O3S
1631001
Sulfamethoxazole, United States Pharmacopeia (USP) Reference Standard
C10H11N3O3S
S2100000
Sulfamethoxazole, European Pharmacopoeia (EP) Reference Standard
C10H11N3O3S